XFOR - X4 Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

XFOR is currently covered by 4 analysts with an average price target of $137.29. This is a potential upside of $133.49 (3512.89%) from yesterday's end of day stock price of $3.8.

X4 Pharmaceuticals's activity chart (see below) currently has 18 price targets and 29 ratings on display. The stock rating distribution of XFOR is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 24 days.

Highest price target for XFOR is $15, Lowest price target is $3.5, average price target is $9.17.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 28-Aug-2025. First documented stock forecast 10-Dec-2017.

Currently out of the existing stock ratings of XFOR, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$9

$5.2 (136.84%)

1 months 27 days ago
(28-Aug-2025)

0/3 (0%)

$5.24 (139.36%)

Buy

$3.5

$-0.3 (-7.89%)

2 months 13 days ago
(12-Aug-2025)

1/2 (50%)

$0.57 (19.45%)

9

Buy

$90

7 months ago
(25-Mar-2025)

0/2 (0%)

$64.35 (250.88%)

Hold

$15

$11.2 (294.74%)

$30

11 months 8 days ago
(17-Nov-2024)

2/2 (100%)

$3.9 (35.14%)

42

Buy

$120

$116.2 (3057.89%)

2 years 5 months 9 days ago
(16-May-2023)

0/1 (0%)

$54 (81.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is XFOR (X4 Pharmaceuticals) average time for price targets to be met?

On average it took 24 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on XFOR (X4 Pharmaceuticals) with a proven track record?

KALPIT PATEL

Which analyst has the most public recommendations on XFOR (X4 Pharmaceuticals)?

Kalpit Patel works at B. RILEY and has 3 price targets and 2 ratings on XFOR

Which analyst is the currently most bullish on XFOR (X4 Pharmaceuticals)?

Joel Beatty with highest potential upside - $596.2

Which analyst is the currently most reserved on XFOR (X4 Pharmaceuticals)?

Swayampakula Ramakanth with lowest potential downside - -$0.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?